A detailed history of Jpmorgan Chase & CO transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 51 shares of LUCD stock, worth $51. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51
Previous 50 2.0%
Holding current value
$51
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$0.75 - $0.88 $0 - $0
1 Added 2.0%
51 $0
Q2 2024

Aug 12, 2024

BUY
$0.67 - $1.04 $10 - $16
16 Added 47.06%
50 $0
Q1 2024

May 10, 2024

SELL
$0.81 - $1.52 $10 - $19
-13 Reduced 27.66%
34 $0
Q4 2023

Feb 12, 2024

BUY
$1.16 - $1.54 $39 - $52
34 Added 261.54%
47 $0
Q3 2023

Nov 14, 2023

BUY
$1.17 - $1.65 $15 - $21
13 New
13 $0
Q2 2022

Aug 11, 2022

SELL
$1.73 - $3.44 $3,115 - $6,195
-1,801 Reduced 76.09%
566 $1,000
Q1 2022

May 11, 2022

SELL
$2.85 - $5.24 $5,785 - $10,637
-2,030 Reduced 46.17%
2,367 $8,000
Q4 2021

Feb 10, 2022

BUY
$4.87 - $11.76 $21,413 - $51,708
4,397 New
4,397 $23,000

Others Institutions Holding LUCD

About Lucid Diagnostics Inc.


  • Ticker LUCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 38,568,500
  • Market Cap $38.6M
  • Description
  • Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...
More about LUCD
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.